Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nexalin Technology (NXL) Invested Capital (2022 - 2025)

Historic Invested Capital for Nexalin Technology (NXL) over the last 4 years, with Q3 2025 value amounting to $4.8 million.

  • Nexalin Technology's Invested Capital fell 381.98% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 381.98%. This contributed to the annual value of $3.7 million for FY2024, which is 1463.85% up from last year.
  • Nexalin Technology's Invested Capital amounted to $4.8 million in Q3 2025, which was down 381.98% from $6.0 million recorded in Q2 2025.
  • In the past 5 years, Nexalin Technology's Invested Capital registered a high of $6.4 million during Q3 2022, and its lowest value of $1.4 million during Q2 2024.
  • For the 4-year period, Nexalin Technology's Invested Capital averaged around $4.0 million, with its median value being $4.0 million (2023).
  • In the last 5 years, Nexalin Technology's Invested Capital plummeted by 6616.52% in 2024 and then soared by 34139.9% in 2025.
  • Nexalin Technology's Invested Capital (Quarter) stood at $5.5 million in 2022, then tumbled by 41.47% to $3.2 million in 2023, then increased by 14.64% to $3.7 million in 2024, then rose by 29.72% to $4.8 million in 2025.
  • Its Invested Capital stands at $4.8 million for Q3 2025, versus $6.0 million for Q2 2025 and $2.3 million for Q1 2025.